Explore pharmacology through interactive simulations
The Law of Mass Action is a principle in chemistry that describes how the rates of chemical reactions are affected by the concentrations of the reactants and products. It basically states that the higher the concentration of the reactants, the faster the reaction will go, and the more product will be produced...
Drug-receptor interactions refer to the binding of a drug molecule to a specific protein receptor in the body. This interaction can trigger a physiological response, such as the activation or inhibition of a particular cellular process. Protein receptors are found on the surface of cells or within the cell membrane, and they play a critical role in cell signaling pathways...
The strength of the drug-receptor interaction is an important factor in determining the potency and effectiveness of a drug. A drug that binds strongly to its receptor will have a greater effect than a drug that binds weakly. Test your understanding of the Law of Mass Action by solving a problem!
Competitive antagonism refers to a situation in which a drug or other chemical compound competes with a natural substance in the body for binding to a specific receptor. This can result in the drug blocking or reducing the effects of the natural substance, or in the natural substance blocking or reducing the effects of the drug...
Competitive antagonism is a type of drug interaction in which a drug (the antagonist) competes with another drug (the agonist) for the same receptor site. This results in a decrease in the efficacy of the agonist by preventing it from binding to the receptor. The antagonist does not activate the receptor, but rather blocks the agonist from doing so.
Non-competitive antagonism in pharmacodynamics refers to a type of drug interaction in which an antagonist does not compete with the agonist for the same receptor site, but rather reduces the overall efficacy of the agonist by altering the function of the receptor or the signaling pathway downstream from the receptor.
Efficacy is a term used in pharmacology to describe the ability of a drug to produce a therapeutic effect. It refers to the maximum effect that a drug can produce and is often contrasted with potency, which is a measure of the amount of drug required to produce a therapeutic effect. Efficacy is determined by the intrinsic activity of the drug and the availability of target receptors.
The task summarizes the effects of competitive, non-competitive, and partial agonists on the efficacy and dose-response curve of agonists. Try to identify the type of interaction.
Sodium channels are specialized proteins in cell membranes that open in response to voltage changes, allowing sodium ions to flow into the cell and trigger electrical signals. Their activity is controlled by activation and inactivation processes, which regulate when the channels open and close.
Sodium channels are key targets for many drugs, including local anesthetics and anticonvulsants, which work by altering the channels' activation (m∞) and inactivation (h∞) properties to reduce excessive neuronal firing or pain signal transmission.
Interactive simulation of hERG potassium channel block — explore frequency-dependent block and dose-response curves to assess cardiac safety and proarrhythmic risk of drug candidates.
Interactive GABAA receptor simulation — explore frequency-dependent block and dose-response curves for GABA activation and benzodiazepine modulation of ligand-gated chloride channels.
more coming soon